Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Microbial Genomics|September 28, 2022
IS26-mediated plasmid reshuffling results in convergence of toxin-antitoxin systems but loss of resistance genes in XDR Klebsiella pneumoniae from a chronic infectionTing L Luo, Brendan W Corey, Erik Snesrud, et al.
Infection Control and Hospital Epidemiology|July 9, 2015
Relationships among cleaning, environmental DNA, and healthcare-associated infections in a new evidence-based design hospitalEmil Lesho, Philip Carling, Eve Hosford, et al.
Journal of Clinical Microbiology|April 5, 2013
Detection of New Delhi metallo-β-lactamase (encoded by blaNDM-1) in Acinetobacter schindleri during routine surveillancePatrick McGann, Michael Milillo, Robert J Clifford, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2015
Fatal outbreak of an emerging clone of extensively drug-resistant Acinetobacter baumannii with enhanced virulenceCrystal L Jones, Megan Clancy, Cary Honnold, et al.
Nature Medicine|November 9, 2019
Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patientsIdan Yelin, Kelly B Flett, Christina Merakou, et al.
Diagnostic Microbiology and Infectious Disease|May 18, 2016
Real time application of whole genome sequencing for outbreak investigation - What is an achievable turnaround time?Patrick McGann, Jessica L Bunin, Erik Snesrud, et al.
Antimicrobial Agents and Chemotherapy|July 3, 2013
Bacterial peritonitis due to Acinetobacter baumannii sequence type 25 with plasmid-borne new delhi metallo-β-lactamase in HondurasPaige E Waterman, Patrick McGann, Erik Snesrud, et al.
Plos One|May 20, 2016
The Challenges of Implementing Next Generation Sequencing Across a Large Healthcare System, and the Molecular Epidemiology and Antibiotic Susceptibilities of Carbapenemase-Producing Bacteria in the Healthcare System of the U.S. Department of DefenseEmil Lesho, Robert Clifford, Fatma Onmus-Leone, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2020
A Diverse Panel of Clinical Acinetobacter baumannii for Research and DevelopmentMadeline R Galac, Erik Snesrud, Francois Lebreton, et al.
The Journal of Infectious Diseases|July 2, 2013
Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infectionsEmil Lesho, Eun-Jeong Yoon, Patrick McGann, et al.
Pageof 4